ICAM1 and neoplasm: Having observed Bevacizumab promotion of TNF-α induction of expression of ICAM-1 and VCAM-1 on the surface of HUVECs above, next we looked at the signs of effective priming of T cells to cross the blood vessel wall into the tumour microenvironment.